Investor List:

Top Pharmaceuticals Pre-Seed Investors in LatAm (Latin America) (7)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Ricardo Salomão, General Partner at Green Rock
Ricardo Salomão
Green Rock·General Partner
Sweet spot: $1.5M
Range: $500K - $3.0M
Investors in Sao Paulo (Brazil)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Wellness & Fitness (Seed), Investors in Wellness & Fitness (Series A), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Series A), Investors in Health IT (Pre-seed), Investors in Health IT (Series A), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Seed), Investors in Therapeutics (Series A), Investors in Drug Delivery (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Pre-seed), Investors in Wellness & Fitness (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Drug Delivery (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Drug Delivery (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Wellness & Fitness (Series A), Investors in Therapeutics (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Drug Delivery (Series B), Investors in Wellness & Fitness (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Wellness & Fitness (Series B), Investors in Therapeutics (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Drug Delivery (Series B), Investors in Therapeutics (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B)
Photo of Mehdi Pirouz, Venture Partner at SF500
Mehdi Pirouz
SF500·Venture Partner
Sweet spot: $250K
Range: $50 - $1M
Investors in Argentina
Photo of Sergio Ricardo Santos, Partner at DNA Capital
Sergio Ricardo Santos
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Health IT (Pre-seed), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Series B), Investors in BioTech (Seed), Investors in Consumer Health (Pre-seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Pedro Bueno, Partner at DNA Capital
Pedro Bueno
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Health IT (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Health IT (Pre-seed), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Series B), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Pre-seed), Investors in Medical Devices (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series B), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Diego Belmar, Scout
Diego Belmar
Scout
Sweet spot: $100K
Range: $1 - $200K
Investors in Chile
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Food and Beverage (Seed), Investors in Food and Beverage (Series A), Investors in Medical Devices (Series A), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series A), Investors in Diagnostics (Pre-seed), Investors in Health IT (Seed), Investors in Diagnostics (Series A), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Food and Beverage (Pre-seed), Investors in Food and Beverage (Series A), Investors in Drug Delivery (Pre-seed), Investors in Food and Beverage (Seed), Investors in Drug Delivery (Series A), Investors in Medical Devices (Seed), Investors in Therapeutics (Series A), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Therapeutics (Pre-seed), Investors in Digital Health (Seed), Investors in LatAm (Latin America) (Other Lists), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Marina Slutzky, Senior Associate
Marina Slutzky
Senior Associate
Sweet spot: $250K
Range: $250K - $500K
Investors in Argentina
Photo of shlomo ovadiah, Managing Partner
shlomo ovadiah
Managing Partner
Sweet spot: $700K
Range: $400K - $30.0M
Investors in Canada, Investors in Dubai (United Arab Emirates), Investors in United States, Investors in Uruguay, Investors in Chile, Investors in Argentina, Investors in Ghana, Investors in Czech Republic, Investors in Hong Kong, Investors in Thailand, Investors in Mexico City (Mexico), Investors in Panama, Investors in Global
Investors in FinTech (Pre-seed), Investors in Insurance (Pre-seed), Investors in Lodging/Hospitality (Pre-seed), Investors in Lodging/Hospitality (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in Insurance (Pre-seed), Investors in Social Networks (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Hardware (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in LatAm (Latin America) (Other Lists), Investors in FinTech (Pre-seed), Investors in Lodging/Hospitality (Pre-seed), Investors in Hardware (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Manufacturing (Series A), Investors in Lodging/Hospitality (Series A), Investors in Web3/Crypto (Pre-seed), Investors in Social Networks (Series A), Investors in Insurance (Series A), Investors in Web3/Blockchain (Series A), Investors in FinTech (Series A), Investors in Web3/Crypto (Series A), Investors in Hardware (Pre-seed), Investors in Insurance (Pre-seed), Investors in Social Networks (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Real Estate/PropTech (Series A), Investors in Web3/Crypto (Series A), Investors in Insurance (Series A), Investors in Diverse Investors (Other Lists), Investors in Hardware (Pre-seed), Investors in FinTech (Pre-seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in FinTech (Series A), Investors in Real Estate/PropTech (Series A), Investors in Hardware (Series A), Investors in Real Estate/PropTech (Series A), Investors in Hardware (Series A), Investors in FinTech (Series A), Investors in Web3/Blockchain (Series A), Investors in Pharmaceuticals (Series A), Investors in Social Networks (Series A), Investors in Lodging/Hospitality (Series A), Investors in Web3/Blockchain (Pre-seed), Investors in Lodging/Hospitality (Series A), Investors in Real Estate/PropTech (Pre-seed), Investors in Manufacturing (Series A), Investors in Web3/Blockchain (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Social Networks (Pre-seed), Investors in Investors who invested in female founders (Other Lists), Investors in Pharmaceuticals (Pre-seed), Investors in Investors who were founders (Other Lists), Investors in Web3/Crypto (Pre-seed), Investors in Social Networks (Series A), Investors in Pharmaceuticals (Series A), Investors in Manufacturing (Series A), Investors in Web3/Blockchain (Series A), Investors in Web3/Crypto (Series A), Investors in Canada (Other Lists), Investors in Insurance (Series A)
Get new data & insights delivered to your inbox
Firms investing in this space